CompletedNot Applicable

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees

United States30 participantsStarted 2011-06

Plain-language summary

Enrolled subjects will receive one bilateral Ulthera® treatment on the knees. Up to 30 subjects will be enrolled. Study photos will be obtained prior to study treatment, immediately following study treatment, and at each post-treatment follow-up visit. Follow-up visits will occur at 90 and 180 days post-treatment.

Who can participate

Age range30 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female, aged 30 to 65 years. * Subject in good health. * Mild to moderate skin laxity around the knees. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. Exclusion Criteria: * Presence of an active systemic or local skin disease that may affect wound healing. * Excessive subcutaneous fat around the knees. * Excessive skin laxity around the knees.

What they're measuring

Improvement in overall lifting and tightening of knee skin laxity.

Timeframe: 90 and 180 days post-treatment

Trial details

NCT IDNCT01708434

SponsorUlthera, Inc

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2012-05

View on ClinicalTrials.gov More Skin Laxity trials